These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. ESHRE guideline: recurrent pregnancy loss: an update in 2022. ; Bender Atik R; Christiansen OB; Elson J; Kolte AM; Lewis S; Middeldorp S; Mcheik S; Peramo B; Quenby S; Nielsen HS; van der Hoorn ML; Vermeulen N; Goddijn M Hum Reprod Open; 2023; 2023(1):hoad002. PubMed ID: 36873081 [TBL] [Abstract][Full Text] [Related]
9. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility. Costello MF; Misso ML; Balen A; Boyle J; Devoto L; Garad RM; Hart R; Johnson L; Jordan C; Legro RS; Norman RJ; Mocanu E; Qiao J; Rodgers RJ; Rombauts L; Tassone EC; Thangaratinam S; Vanky E; Teede HJ; Hum Reprod Open; 2019; 2019(1):hoy021. PubMed ID: 31486807 [TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
11. Strategies to improve the implementation of healthy eating, physical activity and obesity prevention policies, practices or programmes within childcare services. Wolfenden L; Barnes C; Jones J; Finch M; Wyse RJ; Kingsland M; Tzelepis F; Grady A; Hodder RK; Booth D; Yoong SL Cochrane Database Syst Rev; 2020 Feb; 2(2):CD011779. PubMed ID: 32036618 [TBL] [Abstract][Full Text] [Related]
13. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ; Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961 [TBL] [Abstract][Full Text] [Related]
14. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ; Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines. Murayama A; Kamamoto S; Murata N; Yamasaki R; Yamada K; Yamashita E; Saito H; Tanimoto T; Ozaki A J Gastroenterol Hepatol; 2023 Apr; 38(4):565-573. PubMed ID: 36518089 [TBL] [Abstract][Full Text] [Related]
16. [Needs assessment to improve the applicability and methodological quality of a German S3 guideline]. Burckhardt M; Hoffmann C; Nink-Grebe B; Sänger S Z Evid Fortbild Qual Gesundhwes; 2018 Apr; 131-132():1-7. PubMed ID: 28958579 [TBL] [Abstract][Full Text] [Related]
18. ESHRE guideline: number of embryos to transfer during IVF/ICSI†. ; Alteri A; Arroyo G; Baccino G; Craciunas L; De Geyter C; Ebner T; Koleva M; Kordic K; Mcheik S; Mertes H; Pavicic Baldani D; Rodriguez-Wallberg KA; Rugescu I; Santos-Ribeiro S; Tilleman K; Woodward B; Vermeulen N; Veleva Z Hum Reprod; 2024 Apr; 39(4):647-657. PubMed ID: 38364208 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Financial Conflicts of Interest and Quality of Evidence Underlying the American Diabetes Association Clinical Practice Guidelines: The Standards of Medical Care in Diabetes, 2021. Shigeta H; Murayama A; Kamamoto S; Saito H; Ozaki A Cureus; 2023 Mar; 15(3):e36567. PubMed ID: 37095789 [TBL] [Abstract][Full Text] [Related]
20. PROTOCOL: Barriers and facilitators to stakeholder engagement in health guideline development: A qualitative evidence synthesis. Magwood O; Riddle A; Petkovic J; Lytvyn L; Khabsa J; Atwere P; Akl EA; Campbell P; Welch V; Smith M; Mustafa RA; Limburg H; Dans LF; Skoetz N; Grant S; Concannon T; Tugwell P Campbell Syst Rev; 2022 Jun; 18(2):e1237. PubMed ID: 36911345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]